/ Not yet recruitingNot Applicable [Translation] Bioequivalence study of butylphthalide soft capsules in humans under fasting conditions
考察健康试验参与者在空腹条件下,单次口服1粒由华夏国药(菏泽)制药有限公司提供的丁苯酞软胶囊(受试制剂,规格:0.1g)与单次口服1粒由石药集团恩必普药业有限公司生产的丁苯酞软胶囊(参比制剂,商品名:恩必普®,规格:0.1g)的药代动力学特征,评价两制剂间的生物等效性和安全性,为该受试制剂注册申请提供依据。
[Translation] The pharmacokinetic characteristics of butylphthalide soft capsules (test formulation, specification: 0.1g) provided by Huaxia Guoyao (Heze) Pharmaceutical Co., Ltd., and butylphthalide soft capsules (reference formulation, trade name: Enbipu®, specification: 0.1g) produced by CSPC Enbipu Pharmaceutical Co., Ltd., were examined under fasting conditions in healthy trial participants. The bioequivalence and safety between the two formulations were evaluated to provide a basis for the registration application of the test formulation.
/ TerminatedNot Applicable 四烯甲萘醌软胶囊在空腹及餐后条件下的人体生物等效性试验
[Translation] Bioequivalence studies of tetraene-naphthoquinone soft capsules in humans under fasting and postprandial conditions.
本研究考察健康研究参与者在空腹及餐后条件下,单次口服由华夏国药(菏泽)制药有限公司提供的四烯甲萘醌软胶囊(受试制剂,规格:15mg)或由Eisai Co.,Ltd.持证的四烯甲萘醌软胶囊(参比制剂,商品名:固力康®,规格:15mg)的药动学特征,评价两制剂的生物等效性及安全性,为该受试制剂注册申请提供依据。
[Translation] This study investigated the pharmacokinetic characteristics of a single oral dose of tetraene-menaquinone soft capsules (test formulation, strength: 15 mg) provided by Huaxia Guoyao (Heze) Pharmaceutical Co., Ltd., or tetraene-menaquinone soft capsules (reference formulation, trade name: Gulikang®, strength: 15 mg) certified by Eisai Co., Ltd., in healthy study participants under fasting and postprandial conditions. The study aimed to evaluate the bioequivalence and safety of the two formulations and provide a basis for the registration application of the test formulation.
100 Clinical Results associated with Shandong Runhua Jirentang Pharmaceutical Co. Ltd.
0 Patents (Medical) associated with Shandong Runhua Jirentang Pharmaceutical Co. Ltd.
100 Deals associated with Shandong Runhua Jirentang Pharmaceutical Co. Ltd.
100 Translational Medicine associated with Shandong Runhua Jirentang Pharmaceutical Co. Ltd.